top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 12/08/2016 Item size : 256208 bytes
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjcvp

Methods and results In this observational study, 5426 Chinese AF patients (77.7 ± 10.7 years, female: 53.1%) with a CHA2DS2-VASc score of 1 were included in the final analysis: of which, 3832 ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Pak-Hei Chan, Wen-Hua Li, Jo-Jo Hai, Koon-Ho Chan, Hung-Fat Tse, Bernard Man-Yung Cheung, Esther W. Chan, Ian C.K. Wong, ...

Date : 01/10/2015
Ehjcvp

A recently published postmarketing study has shown that dabigatran causes a significantly higher risk of extracranial bleeding than VKAs in clinical practice.3 It was also found that NVAF patients ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Herbert J.A. Rolden, Janneke P.C. Grutters, Gert Jan van der Wilt, Angela H.E.M. Maas

Date : 01/07/2015
Ehjcvp

The most important public health goal in stroke prevention for patients with atrial fibrillation (AF) is to treat a larger proportion of patients with risk factors for stroke with oral ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Sean D. Pokorney, Christopher B. Granger

Date : 01/04/2015 Item size : 159100 bytes
Ehjcvp

Anti-coagulantAnti-plateletAtrial fibrillationBleeding,HaemorrhageNovel oral anti-coagulantStrokeVitamin K antagonistIntroduction In patients with atrial fibrillation (AF), Vitamin K antagonists ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Ariel Dogliotti, Robert P. Giugliano

Date : 01/01/2015